Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.19 -0.25 (-1.22%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Total Non-Current Liabilities (2010 - 2026)

Updated

Acadia Pharmaceuticals' Total Non-Current Liabilities came in at $420.98 million for Q2 2026, up 12.4% from $374.63 million a year earlier and up 22.2% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals' Total Non-Current Liabilities was $317.67 million, down 27.3% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $436.91 million in FY2024 (+44.6%), $302.05 million in FY2023 (+69.4%), $178.33 million in FY2022 (+17.2%) and $152.19 million in FY2021 (+1.2%).
  • The Q2 2026 figure represents the highest quarterly Total Non-Current Liabilities since Q4 2024.
  • Year-over-year, Total Non-Current Liabilities increased in four of the last eight quarters, with growth averaging 8.8%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q4 2023 (growth of 69.4%), and the weakest in Q4 2025 (a decline of 27.3%).
  • Business Quant data shows ACAD's Total Non-Current Liabilities at $344.53 million (Q1 2026), $317.67 million (Q4 2025) and $399.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Acadia Pharmaceuticals 3.47 Bn -4.91 Mn 279.64 Mn 420.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 420.98 Mn
Mar 31, 2026 344.53 Mn
Dec 31, 2025 317.67 Mn
Sep 30, 2025 399.61 Mn
Jun 30, 2025 374.63 Mn
Mar 31, 2025 347.16 Mn
Dec 31, 2024 436.91 Mn
Sep 30, 2024 384.37 Mn
Jun 30, 2024 385.04 Mn
Mar 31, 2024 379.79 Mn
Dec 31, 2023 302.05 Mn
Sep 30, 2023 257.71 Mn
Jun 30, 2023 237.72 Mn
Mar 31, 2023 275.74 Mn
Dec 31, 2022 178.33 Mn
Sep 30, 2022 170.34 Mn
Jun 30, 2022 172.37 Mn
Mar 31, 2022 175.08 Mn
Dec 31, 2021 152.19 Mn
Sep 30, 2021 145.90 Mn
API Access

Acadia Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ACAD&period=max&api_key=YOUR_API_KEY